Title : Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis.

Pub. Date : 2019 Jul 2

PMID : 31240976






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background The angiotensin-receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin-converting enzyme inhibitor enalapril in terms of reducing cardiovascular mortality in the PARADIGM-HF (Prospective Comparison of ARNI with angiotensin-converting enzyme inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure) study. Valsartan angiotensin I converting enzyme Homo sapiens